[
  {
    "ts": "2026-01-27T09:10:00+00:00",
    "headline": "Roche Obesity Shot Helps Patients Lose Weight in Midstage Trial",
    "summary": "Roche  Holding said an experimental injection achieved positive results in a midstage clinical trial by helping patients shed weight, paving the way for the start of the company’s first late-stage obesity study.  Eli Lilly  and  Novo Nordisk’s  GLP-1 drugs currently dominate the obesity-drug market, but big drugmakers including Roche, Pfizer and Amgen, as well as smaller players, are trying to come up with new treatments to challenge them.  Roche is looking to establish an obesity franchise with several drug candidates under development that it aims to launch as standalone treatments or combined among them, with the goal of becoming a top three player in the market.",
    "url": "https://www.wsj.com/health/pharma/roche-says-weight-loss-shot-achieved-positive-results-in-midstage-trial-4273608d?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "f3dd70d2-dbd5-3e48-8e50-4f676592cdb0",
      "content": {
        "id": "f3dd70d2-dbd5-3e48-8e50-4f676592cdb0",
        "contentType": "STORY",
        "title": "Roche Obesity Shot Helps Patients Lose Weight in Midstage Trial",
        "description": "",
        "summary": "Roche  Holding said an experimental injection achieved positive results in a midstage clinical trial by helping patients shed weight, paving the way for the start of the company’s first late-stage obesity study.  Eli Lilly  and  Novo Nordisk’s  GLP-1 drugs currently dominate the obesity-drug market, but big drugmakers including Roche, Pfizer and Amgen, as well as smaller players, are trying to come up with new treatments to challenge them.  Roche is looking to establish an obesity franchise with several drug candidates under development that it aims to launch as standalone treatments or combined among them, with the goal of becoming a top three player in the market.",
        "pubDate": "2026-01-27T09:10:00Z",
        "displayTime": "2026-01-27T09:10:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/f3dd70d2-dbd5-3e48-8e50-4f676592cdb0/roche-obesity-shot-helps.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/6776476caeb6f0775b332aa36f02d84b",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mMw5hQjYBtg6SHEiEZH_mg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/6776476caeb6f0775b332aa36f02d84b.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dcG7Cmj4Eht4.1NHh1nEIw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/6776476caeb6f0775b332aa36f02d84b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/roche-says-weight-loss-shot-achieved-positive-results-in-midstage-trial-4273608d?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "RHHBY"
            },
            {
              "symbol": "RHHVF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "ZLDPF"
            },
            {
              "symbol": "CRMO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-27T13:18:00+00:00",
    "headline": "Baseline Therapeutics Launches to Advance GLP-1RA Phase 3 Program in Alcohol Use Disorder",
    "summary": "SAN FRANCISCO, January 27, 2026--Baseline Therapeutics, Inc. (\"Baseline\"), a clinical-stage biotechnology company developing addiction therapeutics, today announced the launch of the company to advance a new generation of pharmacotherapies for substance use disorders.",
    "url": "https://finance.yahoo.com/news/baseline-therapeutics-launches-advance-glp-131800103.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "2cb40209-aa57-3127-bd51-ba956f665dd8",
      "content": {
        "id": "2cb40209-aa57-3127-bd51-ba956f665dd8",
        "contentType": "STORY",
        "title": "Baseline Therapeutics Launches to Advance GLP-1RA Phase 3 Program in Alcohol Use Disorder",
        "description": "",
        "summary": "SAN FRANCISCO, January 27, 2026--Baseline Therapeutics, Inc. (\"Baseline\"), a clinical-stage biotechnology company developing addiction therapeutics, today announced the launch of the company to advance a new generation of pharmacotherapies for substance use disorders.",
        "pubDate": "2026-01-27T13:18:00Z",
        "displayTime": "2026-01-27T13:18:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/e2cb147e6016124efe4a48bf300e0382",
          "originalWidth": 480,
          "originalHeight": 218,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jOmhlf3QVvsLRIsULzbplg--~B/aD0yMTg7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/e2cb147e6016124efe4a48bf300e0382.cf.webp",
              "width": 480,
              "height": 218,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iOiEPbgb1ojn2jGwUCRU2Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/e2cb147e6016124efe4a48bf300e0382.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/baseline-therapeutics-launches-advance-glp-131800103.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/baseline-therapeutics-launches-advance-glp-131800103.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-27T13:00:22+00:00",
    "headline": "These 4 Measures Indicate That Pfizer (NYSE:PFE) Is Using Debt Extensively",
    "summary": "David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...",
    "url": "https://finance.yahoo.com/news/4-measures-indicate-pfizer-nyse-130022576.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "52f9cb21-ce44-3cc7-ad37-aede5c0686d1",
      "content": {
        "id": "52f9cb21-ce44-3cc7-ad37-aede5c0686d1",
        "contentType": "STORY",
        "title": "These 4 Measures Indicate That Pfizer (NYSE:PFE) Is Using Debt Extensively",
        "description": "",
        "summary": "David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...",
        "pubDate": "2026-01-27T13:00:22Z",
        "displayTime": "2026-01-27T13:00:22Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QSfydsi7Q.1zNEN99DbEyw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hi2p7oczHh8yTJraqZcczg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/4-measures-indicate-pfizer-nyse-130022576.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/4-measures-indicate-pfizer-nyse-130022576.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-27T10:38:20+00:00",
    "headline": "Pfizer’s CEO on leading after a moonshot—and making deals with Trump",
    "summary": "Also: All the news and watercooler chat from Fortune.",
    "url": "https://finance.yahoo.com/news/pfizer-ceo-leading-moonshot-making-103820439.html",
    "source": "Fortune",
    "provider": "yfinance",
    "raw": {
      "id": "472bff5d-d7b2-381d-96b2-3e94ced657c6",
      "content": {
        "id": "472bff5d-d7b2-381d-96b2-3e94ced657c6",
        "contentType": "STORY",
        "title": "Pfizer’s CEO on leading after a moonshot—and making deals with Trump",
        "description": "",
        "summary": "Also: All the news and watercooler chat from Fortune.",
        "pubDate": "2026-01-27T10:38:20Z",
        "displayTime": "2026-01-27T10:38:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/fortune_175/517b2054484b1fe9103cb08a67df31b1",
          "originalWidth": 2048,
          "originalHeight": 1365,
          "caption": "Fortune Editor-in-Chief Alyson Shontell in conversation with Albert Bourla, Chairman and CEO of Pfizer, at the Fortune CEO Initiative in Washington, D.C. on Nov. 15, 2021.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/brcR58vqAweIFNpSIOtrRw--~B/aD0xMzY1O3c9MjA0ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/fortune_175/517b2054484b1fe9103cb08a67df31b1.cf.webp",
              "width": 2048,
              "height": 1365,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JwV66f8fmxSJtSOvhleSww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/fortune_175/517b2054484b1fe9103cb08a67df31b1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Fortune",
          "url": "http://fortune.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-ceo-leading-moonshot-making-103820439.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-ceo-leading-moonshot-making-103820439.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "TGT"
            },
            {
              "symbol": "BNTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-27T10:32:32+00:00",
    "headline": "What Are Wall Street Analysts' Target Price for Pfizer Stock?",
    "summary": "Pfizer has lagged the broader market over the past year, and analysts remain cautious about its future outlook.",
    "url": "https://www.barchart.com/story/news/37243450/what-are-wall-street-analysts-target-price-for-pfizer-stock",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "e38ca810-0fa2-3ef1-a2fa-b1854a9c2628",
      "content": {
        "id": "e38ca810-0fa2-3ef1-a2fa-b1854a9c2628",
        "contentType": "STORY",
        "title": "What Are Wall Street Analysts' Target Price for Pfizer Stock?",
        "description": "",
        "summary": "Pfizer has lagged the broader market over the past year, and analysts remain cautious about its future outlook.",
        "pubDate": "2026-01-27T10:32:32Z",
        "displayTime": "2026-01-27T10:32:32Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/d7302595652f734ec569665a48732fef",
          "originalWidth": 1254,
          "originalHeight": 836,
          "caption": "Pfizer Inc_ logo sign-by JHVEPhoto via iStock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/p3FsWbz7qG5HOq9YXp12wQ--~B/aD04MzY7dz0xMjU0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/barchart_com_477/d7302595652f734ec569665a48732fef.cf.webp",
              "width": 1254,
              "height": 836,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/phs7vu4maW0UNXOOYOvh6A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/d7302595652f734ec569665a48732fef.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/37243450/what-are-wall-street-analysts-target-price-for-pfizer-stock",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/wall-street-analysts-target-price-103232212.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BNTX"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]